Aster DM Healthcare Limited

NSE:ASTERDM.NS

420.95 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 10,018.79,735.937,106.133,166.332,153.732,623.231,921.428,16326,621.227,277.926,495.625,043.423,715.923,212.222,588.722,677.117,606.323,013.723,216.620,868.820,285.922,010.321,50118,369.317,746.517,842.8718,142.815,661.515,564.4
Cost of Revenue 7,109.76,873.510,717.59,5929,654.99,268.39,542.68,388.28,119.17,206.17,459.77,282.97,140.96,071.96,8266,866.25,842.314,473.36,950.96,1586,272.913,081.46,548.25,498.65,520.34,838.626,023.94,808.64,918.3
Gross Profit 2,9092,862.426,388.623,574.322,498.823,354.922,378.819,774.818,502.120,071.819,035.917,760.516,57517,140.315,762.715,810.911,7648,540.416,265.714,710.814,0138,928.914,952.812,870.712,226.213,004.2512,118.910,852.910,646.1
Gross Profit Ratio 0.290.2940.7110.7110.70.7160.7010.7020.6950.7360.7180.7090.6990.7380.6980.6970.6680.3710.7010.7050.6910.4060.6950.7010.6890.7290.6680.6930.684
Reseach & Development Expenses 00000144.800045.80000000000000000000
General & Administrative Expenses 2,259.1-1,177.43,2972,977.42,869.92,923.52,659.32,5232,277.63,436.22,157.41,9921,877.22,923.21,752.31,720.91,186.2-4,533.41,807.61,726.21,638.7-3,843.91,585.81,430.71,424.41,257.791,357.51,2781,258.2
Selling & Marketing Expenses -381.43,0300002,037.20001,372.9000789.9000998.6000967.50001,197.3000
SG&A 1,877.71,852.63,2972,977.42,869.92,923.52,659.32,5232,277.64,809.12,157.41,9921,877.23,713.11,752.31,720.91,186.2-3,534.81,807.61,726.21,638.7-2,876.41,585.81,430.71,424.41,257.791,357.51,2781,258.2
Other Expenses 487.2-8.979.585.9-97.5-16.5-113.2-7.4213.2-386.2-525-536.5-650.7-2,5065779.465.219539.241.332.5-47.957.7161.817391.21175.39592.9
Operating Expenses 1,877.71,852.623,062.622,073.220,606.820,328.219,668.718,287.817,171.216,09116,033.815,268.314,565.212,129.214,056.614,629.411,883.85,89513,812.513,752.513,036.35,934.513,109.712,374.311,724.610,930.4311,08810,420.411,033
Operating Income 1,031.31,009.83,3211,5141,702.53,017.52,606.81,478.51,330.93,469.93,002.12,492.22,009.85,011.11,706.11,181.5-119.82,645.42,453.2958.3976.72,994.41,843.1496.4501.62,073.821,030.9432.5-386.9
Operating Income Ratio 0.1030.1040.090.0460.0530.0920.0820.0520.050.1270.1130.10.0850.2160.0760.052-0.0070.1150.1060.0460.0480.1360.0860.0270.0280.1160.0570.028-0.025
Total Other Income Expenses Net 195.7-258-986.4-1,565.6-970-959.7-872.4-772.1-478.7-971.7-1,188.7-1,140.2-1,304.9-3,791.4-553.8-655.8-727.4-1,182.8-856.5-840-853.9-751.7-544.1-255.6-181.681.38553.2-366.4-340.9
Income Before Tax 1,227751.82,334.6-51.6732.52,057.81,734.4706.4852.22,498.21,813.41,352704.91,219.71,152.3525.7-847.21,462.61,596.7118.3122.82,242.71,299240.83202,155.21,584.166.1-727.8
Income Before Tax Ratio 0.1220.0770.063-0.0020.0230.0630.0540.0250.0320.0920.0680.0540.030.0530.0510.023-0.0480.0640.0690.0060.0060.1020.060.0130.0180.1210.0870.004-0.047
Income Tax Expense 389.9305.7242.4101.7534231.9144.1165.454.541.9131.475.8108.952.577.8103.238.7-0.582.449.622.344.3167101.6116.5103.1-7.692.772.6
Net Income 51,451.8-240.31,792.1-307.9491,707.71,393.9462.1695.42,262.71,483.41,069.1444.71,053.9924.2328.6-829.31,311.11,391.231.232.62,093.31,003.4110.41241,901.411,551.55.1-769.3
Net Income Ratio 5.136-0.0250.048-0.0090.0020.0520.0440.0160.0260.0830.0560.0430.0190.0450.0410.014-0.0470.0570.060.0010.0020.0950.0470.0060.0070.1070.0860-0.049
EPS 103.45-0.483.6-0.620.0993.432.80.931.44.552.982.150.892.121.860.89-1.672.632.780.060.064.220.220.253.763.330.01-1.66
EPS Diluted 103.19-0.483.6-0.620.0993.432.80.931.44.552.982.150.892.121.860.89-1.672.632.770.060.064.21.990.220.253.763.330.01-1.66
EBITDA 1,635.41,593.45,636.43,785.63,8965,203.54,581.93,372.23,289.84,804.84,091.53,529.42,899.33,640.13,346.52,800.21,502.73,847.63,892.92,492.42,260.53,358.62,6521,408.91,458.42,726.791,911.21,477490
EBITDA Ratio 0.1630.1640.1520.1140.1210.160.1440.120.1240.1760.1540.1410.1220.1570.1480.1230.0850.1670.1680.1190.1110.1530.1230.0770.0820.1530.1050.0940.031